Vasculitis Flashcards

1
Q

What is polyarteritis nodosa?

A

a multisystem vasculitis characterized by segmental necrotizing vasculitis involving predominantly medium-sized blood vessels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PAN is more common in males

A

T - ratio of 1.5:1 M :F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Associations with PAN

A

Infections
- HBV
- Group A strep

Inflammatory diseases (e.g. inflammatory bowel disease),

Malignancies (especially hairy cell leukemia)

Medications
- minocycline

VEXAS ( vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Genetic associaiton for children with PAN?

A

CECR1 gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical presentation of PAN?

A

Constitutional symptoms - weight loss, fever

Arthralgia
Sensory and motor neuropahty (mononeuritis multiplex)
Myagias
Abdo pain

Renal involvement - renovascular HTN and renal failure

Orchitis

thrombotic microangiopathy or vasculitic arterial occlusion resulting in:
Stroke
Ischaemic cardiomyopathy
Mesenteric ischaemia –> bowel perforation

*lungs are spared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PAN is associated with glomerulonephritis

A

False - it is ass with renovascular HTN and renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Poor prognostic factors for PAN

A

GI involvement, 1 year survival rate < 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cutaneous findings with PAN?

A

Tender erythematous nodules
Livedo Racemosa
Retiform purpura
Ulceration
Palpable purpura
Atrophe blanche

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A skin predominant form of Polyarteritis nodosa occurs in 30% of cases

A

false - only 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cutaneous PAN often progresses to systemic PAN

A

False - this is rare.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ix findings for PAN

A

No lab test is diagnostic

ANCA - negative

Leukocytosis
Thrombocytosis
ESR often elevated

HBV and HCV should be performed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Histology of PAN

A

segmental necrotizing vascu-
litis of medium-sized muscular arteries

medium-sized vessels are located within the deep dermis and subcutaneous fat,

although overlying small blood vessels
and nearby fat lobules may be secondarily involved.

DIF, if performed, may show deposits of C3, IgM, and fibrin within or around vessel walls, but this is of uncertain significance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Differences between ANCA ass vasculitis and PAN?

A

ANCA = glomerulonephritis and pulmonary involvement, circulating ANCAs

PAN = renovascular HTN, lacks pulmonary involvement, ANCA negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of systemic PAN?

A

1st Line:
Oral corticosteroids - 1mg / kg / day
tapered over 6 months

Or Oral corticosteroids + plasmaphoresis + entecavir

One half of patients will acheive remission or cure with corticosteroids alone

Steroid spating agents:
- AZA
- MTX
- IVIG
- cyclophosphamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rx of cutaneous PAN?

A

First Line:
- NSAIDs
- Corticosteorids (oral, topical, IL)

Second line:
- Dapsone
- Colchicine
- Aza
- MTX

Third line:
- pentoxyfyline
- HCQ
- IVIG
- MMF
- TNF inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ix for suspected Vasculitis?

A

Lesional skin biopsies (early lesions)
- Histology
- DIF

For CSVV - punch biopsy
For mediusm vessel - Ideally incisional, or deep punch (telescope) of a subcut nodules > reiform purpura > edge of an ulcer

Bloods:
- FBC and film
- UEC
- LFTs
- C3 / C4
- ANCA
- Cryoglobulins
- ANA, ENA, dsDNA, RF
- Hep B / C / HIV
- ASOT, anti DNA-ase B titres
- SPEP, age app malignancy screening

  • pre-immunosupression screen
  • G6PD (consider HLA 13:01 in chinese)
  • Urinalysis
17
Q

Describe

18
Q

Is PAN more common in men or women?

A

1.5 : 1

M : F

19
Q

ANCA ass vasculitis - disease and antibody association

21
Q

Acute haemorrhagic oedema is more common in Males (70%) compared to females (30%)

22
Q

Who does acute haemorrhagic oedema of infancy affect?

A

Children < 2 years old
Boys

23
Q

How can you distinguish between urticaria and urticarial vasculitis

A

Urticarial vasculitis:

Duration of lesion
Resolution with bruising
Pain
Brown lesion of diascopy

24
Q

Ix for urticarial vasculitis?

A

ANA
ENA
C3 / C4 / C1q solid phase assay

FBC
UEC - urinalysis

ESR

25
What is HUVS?
Hypocomplementemic urticarial vasculitis syndrome A more severe form of hypocomplementaemic vasculitis characterised by ● Two major criteria: (1) urticaria for 6 months; and (2) hypocomplementemia – plus – ● Two or more minor criteria: (1) vasculitis on skin biopsy; (2) arthralgia or arthritis; (3) uveitis or episcleritis; (4) glomerulonephritis; (5) recurrent abdominal pain; or (6) positive C1q precipitin test with a low C1q level.
26
How do you treat EED?
1st Line - Dapsone Adjuncts: - NSAIDs - Nicotinamide 2nd Line: - Tetracyclines - Hydroxychloroquine - Cochicine
27
How does granuloma faciale present?
Dermal, chronic dermatitis characterized by red–brown to violaceous plaques or nodules. The face is the most common site of involvement and lesions are more often solitary than multiple.
28
What is the surface of the skin described as in granuloma faciale?
Orange peel surface
29
Pathology of granuloma Faciale
Normal epidermus Dermal infiltrate with a Grenz Zone Diffuse, nodular, perivascular neutrophils, lymphocytes and plasma cells admixed with eosinophils
30
1st line treatment of Granuloma Faciale
TCI TCI Il steroids
31
Systemic treatment for granuloma faciale
Dapsone Plaquenil
32
33
Physical therapy for granuloma faciale?
Cryosurgery Electrosurgery Surgical excision, Dermabrasion, and CO2 or pulsed dye laser therapy may be effective Laser therapy targeting the prominent vascular component (e.g. 595 nm pulsed dye laser, 532 nm potassium titanyl phosphate laser) has led to improvement in a number of patients.